Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality

ClinicalTrials.gov ID: NCT03594175

Public ClinicalTrials.gov record NCT03594175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use of CUSA-081 for Dysfunctional Central Venous Access Devices (CVADs)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy and safety of CUSA-081 (diluted reteplase) in the restoration of central venous access device (CVAD) functionality in participants 18 years and older.

Study identification

NCT ID
NCT03594175
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Chiesi Farmaceutici S.p.A.
Industry
Enrollment
462 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 12, 2020 (Actual)
Primary completion
Jun 8, 2023 (Actual)
Completion
Jul 10, 2023 (Actual)
Last update posted
Aug 23, 2024

2020 – 2023

United States locations

U.S. sites
35
U.S. states
23
U.S. cities
34
Facility City State ZIP Site status
Chiesi Investigational Site Little Rock Arkansas 72205 —
Chiesi Investigational Site Redlands California 92373 —
Chiesi Investigational Site Stockton California 95204 —
Chiesi Investigational Site Norwich Connecticut 06360 —
Chiesi Investigational Site Newark Delaware 19718 —
Chiesi Investigational Site Jacksonville Florida 32209 —
Chiesi Investigational Site Miami Florida 33155-3009 —
Chiesi Investigational Site Plantation Florida 33322 —
Chiesi Investigational Site Weeki Wachee Florida 34607 —
Chiesi Investigational Site Weston Florida 33331 —
Chiesi Investigational Site Atlanta Georgia 30322 —
Chiesi Investigational Site Honolulu Hawaii 96814 —
Chiesi Investigational Site Quincy Illinois 62301 —
Chiesi Investigational Site New Albany Indiana 47150 —
Einspahr Topeka Kansas 66606 —
Chiesi Investigational Site Lewiston Maine 04240 —
Chiesi Investigational Site Hannibal Missouri 63401 —
Chiesi Investigational Site Kalispell Montana 59901-3158 —
Chiesi Investigational Site Omaha Nebraska 68131 —
Chiesi Investigational Site Howell Township New Jersey 07731 —
Chiesi Investigational Site New Brunswick New Jersey 08901 —
Chiesi Investigational Site Durham North Carolina 27710 —
Chiesi Investigational Site Winston-Salem North Carolina 27103 —
Chiesi Investigational Site Toledo Ohio 43608 —
Chiesi Investigational Site Toledo Ohio 43614 —
Chiesi Investigational Site Oklahoma City Oklahoma 73104 —
Chiesi Investigational Site Bend Oregon 97701 —
Chiesi Investigational Site Portland Oregon 97210 —
Chiesi Investigational Site Bethlehem Pennsylvania 18015 —
Chiesi Investigational Site Charleston South Carolina 29414 —
Chiesi Investigational Site Spartanburg South Carolina 29303 —
Chiesi Investigational Site Franklin Tennessee 37067 —
Chiesi Investigational Site Knoxville Tennessee 37920 —
Chiesi Investigational Site Fredericksburg Virginia 22401 —
Chiesi Investigational Site Lynchburg Virginia 24501 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03594175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03594175 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →